Literature DB >> 12096207

Raised plasma concentrations of alpha-defensins in patients with idiopathic pulmonary fibrosis.

H Mukae1, H Iiboshi, M Nakazato, T Hiratsuka, M Tokojima, K Abe, J Ashitani, J Kadota, S Matsukura, S Kohno.   

Abstract

BACKGROUND: Neutrophils are thought to play an important role in the pathogenesis of idiopathic pulmonary fibrosis (IPF). Human neutrophils contain antimicrobial and cytotoxic peptides in the azurophil granules which belong to a family of mammalian neutrophil peptides named alpha-defensins. A study was undertaken to investigate the role of alpha-defensins in the pathogenesis of IPF.
METHODS: The concentrations of alpha-defensins (human neutrophil peptides (HNPs) 1, 2, and 3) in plasma and bronchoalveolar lavage (BAL) fluid of 30 patients with IPF and 15 healthy subjects were measured by radioimmunoassay.
RESULTS: The concentrations of alpha-defensins in plasma, but not in BAL fluid, were significantly higher in IPF patients than in controls. BAL fluid concentrations of interleukin (IL)-8 in patients with IPF, which were significantly higher than in controls, correlated with those of alpha-defensins. An inverse relationship was seen between plasma alpha-defensin levels and the arterial oxygen tension (PaO(2)) and pulmonary function (vital capacity (%VC), forced expiratory volume in 1 second (FEV(1)), and carbon monoxide transfer factor (%TLCO)) in patients with IPF. Plasma levels of alpha-defensins also correlated with the clinical course in IPF patients with an acute exacerbation. Immunohistochemically, positive staining was observed inside and outside neutrophils in the alveolar septa, especially in dense fibrotic areas.
CONCLUSION: These findings suggest that alpha-defensins play an important role in the pathogenesis of IPF, and that the plasma alpha-defensin level may be a useful marker of disease severity and activity.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12096207      PMCID: PMC1746385          DOI: 10.1136/thorax.57.7.623

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  34 in total

1.  Direct cytotoxicity of polymorphonuclear leukocyte granule proteins to human lung-derived cells and endothelial cells.

Authors:  D G Okrent; A K Lichtenstein; T Ganz
Journal:  Am Rev Respir Dis       Date:  1990-01

2.  Neutrophilic alveolitis in idiopathic pulmonary fibrosis. The role of interleukin-8.

Authors:  J P Lynch; T J Standiford; M W Rolfe; S L Kunkel; R M Strieter
Journal:  Am Rev Respir Dis       Date:  1992-06

3.  The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis.

Authors:  M Turner-Warwick; P L Haslam
Journal:  Am Rev Respir Dis       Date:  1987-01

Review 4.  Defensins: key players or bystanders in infection, injury, and repair in the lung?

Authors:  S van Wetering; P J Sterk; K F Rabe; P S Hiemstra
Journal:  J Allergy Clin Immunol       Date:  1999-12       Impact factor: 10.793

5.  Characterization of the inflammatory and immune effector cells in the lung parenchyma of patients with interstitial lung disease.

Authors:  G W Hunninghake; O Kawanami; V J Ferrans; R C Young; W C Roberts; R G Crystal
Journal:  Am Rev Respir Dis       Date:  1981-04

6.  Plasma and BAL fluid concentrations of antimicrobial peptides in patients with Mycobacterium avium-intracellulare infection.

Authors:  J Ashitani ; H Mukae; T Hiratsuka; M Nakazato; K Kumamoto; S Matsukura
Journal:  Chest       Date:  2001-04       Impact factor: 9.410

7.  Serum surfactant proteins A and D as prognostic factors in idiopathic pulmonary fibrosis and their relationship to disease extent.

Authors:  H Takahashi; T Fujishima; H Koba; S Murakami; K Kurokawa; Y Shibuya; M Shiratori; Y Kuroki; S Abe
Journal:  Am J Respir Crit Care Med       Date:  2000-09       Impact factor: 21.405

8.  Granulocyte-colony stimulating factor levels in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis.

Authors:  J Ashitani; H Mukae; H Taniguchi; T Ihi; J Kadota; S Kohno; S Matsukura
Journal:  Thorax       Date:  1999-11       Impact factor: 9.139

9.  Recombinant granulocyte colony-stimulating factor induces production of human neutrophil peptides in lung cancer patients with neutropenia.

Authors:  J Ashitani; M Nakazato; H Mukae; H Taniguchi; Y Date; S Matsukura
Journal:  Regul Pept       Date:  2000-11-24

10.  Characteristic elevation of matrix metalloproteinase activity in idiopathic interstitial pneumonias.

Authors:  M Suga; K Iyonaga; T Okamoto; Y Gushima; H Miyakawa; T Akaike; M Ando
Journal:  Am J Respir Crit Care Med       Date:  2000-11       Impact factor: 21.405

View more
  29 in total

1.  Nonenzymatic conversion of ADP-ribosylated arginines to ornithine alters the biological activities of human neutrophil peptide-1.

Authors:  Linda A Stevens; Joseph T Barbieri; Grzegorz Piszczek; Amy N Otuonye; Rodney L Levine; Gang Zheng; Joel Moss
Journal:  J Immunol       Date:  2014-11-12       Impact factor: 5.422

Review 2.  Cationic host defence peptides: multifaceted role in immune modulation and inflammation.

Authors:  Ka-Yee Choi; Leola N Y Chow; Neeloffer Mookherjee
Journal:  J Innate Immun       Date:  2012-03-14       Impact factor: 7.349

Review 3.  Laboratory diagnosis of Prosthetic Joint Infections: Current concepts and present status.

Authors:  Raju Vaishya; Raman Sardana; Hena Butta; Leena Mendiratta
Journal:  J Clin Orthop Trauma       Date:  2018-10-16

Review 4.  Acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Harold R Collard; Bethany B Moore; Kevin R Flaherty; Kevin K Brown; Robert J Kaner; Talmadge E King; Joseph A Lasky; James E Loyd; Imre Noth; Mitchell A Olman; Ganesh Raghu; Jesse Roman; Jay H Ryu; David A Zisman; Gary W Hunninghake; Thomas V Colby; Jim J Egan; David M Hansell; Takeshi Johkoh; Naftali Kaminski; Dong Soon Kim; Yasuhiro Kondoh; David A Lynch; Joachim Müller-Quernheim; Jeffrey L Myers; Andrew G Nicholson; Moisés Selman; Galen B Toews; Athol U Wells; Fernando J Martinez
Journal:  Am J Respir Crit Care Med       Date:  2007-06-21       Impact factor: 21.405

5.  Gene expression profiles of acute exacerbations of idiopathic pulmonary fibrosis.

Authors:  Kazuhisa Konishi; Kevin F Gibson; Kathleen O Lindell; Thomas J Richards; Yingze Zhang; Rajiv Dhir; Michelle Bisceglia; Sebastien Gilbert; Samuel A Yousem; Jin Woo Song; Dong Soon Kim; Naftali Kaminski
Journal:  Am J Respir Crit Care Med       Date:  2009-04-10       Impact factor: 21.405

6.  Human neutrophil peptide in lung chronic allograft dysfunction.

Authors:  Cavan Reilly; Tereza Cervenka; Marshall I Hertz; Trisha Becker; Chris H Wendt
Journal:  Biomarkers       Date:  2011-10-11       Impact factor: 2.658

Review 7.  Molecular biomarkers in idiopathic pulmonary fibrosis.

Authors:  Brett Ley; Kevin K Brown; Harold R Collard
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-09-26       Impact factor: 5.464

8.  Application of Antimicrobial Peptides of the Innate Immune System in Combination With Conventional Antibiotics-A Novel Way to Combat Antibiotic Resistance?

Authors:  Maria S Zharkova; Dmitriy S Orlov; Olga Yu Golubeva; Oleg B Chakchir; Igor E Eliseev; Tatyana M Grinchuk; Olga V Shamova
Journal:  Front Cell Infect Microbiol       Date:  2019-04-30       Impact factor: 5.293

9.  ADP-ribosylation of human defensin HNP-1 results in the replacement of the modified arginine with the noncoded amino acid ornithine.

Authors:  Linda A Stevens; Rodney L Levine; Bernadette R Gochuico; Joel Moss
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-06       Impact factor: 11.205

10.  Alpha-defensins increase lung fibroblast proliferation and collagen synthesis via the beta-catenin signaling pathway.

Authors:  Weihong Han; Wei Wang; Kamal A Mohammed; Yunchao Su
Journal:  FEBS J       Date:  2009-10-08       Impact factor: 5.542

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.